Transcriptional co-factors and hepatic energy metabolism

Molecular and Cellular Endocrinology

Volumn 332, Issue 1-2, 2011, Pages 21-31

  Sommerfeld, Anke ^a   Krones Herzig, Anja ^a   Herzig, Stephan ^a  

^a GERMAN CANCER RESEARCH CENTER   (Germany)

Author keywords

Liver; Metabolic Syndrome; Metabolism; Transcriptional co factors

Indexed keywords

ACYLTRANSFERASE; COACTIVATOR ASSOCIATED ARGININE METHYLTRANSFERASE; HISTONE ACETYLTRANSFERASE GCN5; HISTONE ACETYLTRANSFERASE PCAF; HISTONE ACETYLTRANSFERASE TRANSFORMATION TRANSCRIPTION DOMAIN ASSOCIATED PROTEIN; HISTONE DEACETYLASE; METHYLTRANSFERASE; NUCLEAR RECEPTOR COACTIVATOR 2; NUCLEAR RECEPTOR DAX 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN; PROTEIN ARGININE METHYLTRANSFERASE; RECEPTOR INTERACTING PROTEIN 140; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; SIRTUIN 1; STEROID RECEPTOR COACTIVATOR 1; TG INTERACTING FACTOR 1; TRANSDUCER OF REGULATED CREB ACTIVITY; TRIPARTITE MOTIF PROTEIN 24; UNCLASSIFIED DRUG;

DNA BINDING; ENERGY BALANCE; ENERGY METABOLISM; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE METABOLISM; HUMAN; LIPID METABOLISM; LIVER METABOLISM; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; LIPID METABOLISM; LIVER; METABOLIC SYNDROME X; NUCLEAR PROTEINS; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC;

EID: 78650523232     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.11.020     Document Type: Review

References (164)

1. Alenghat T., Meyers K., Mullican S.E., Leitner K., Adeniji-Adele A., Avila J., Bucan M., Ahima R.S., Kaestner K.H., Lazar M.A. Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature 2008, 456:997-1000.
2. Andrews R.C., Walker B.R. Glucocorticoids and insulin resistance: old hormones, new targets. Clin. Sci. (Lond.) 1999, 96:513-523.
3. Argiles J.M., Busquets S., Lopez-Soriano F.J. Metabolic interrelationships between liver and skeletal muscle in pathological states. Life Sci. 2001, 69:1345-1361.
4. Bannister A.J., Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 1996, 384:641-643.
5. Barthel R., Tsytsykova A.V., Barczak A.K., Tsai E.Y., Dascher C.C., Brenner M.B., Goldfeld A.E. Regulation of tumor necrosis factor alpha gene expression by mycobacteria involves the assembly of a unique enhanceosome dependent on the coactivator proteins CBP/p300. Mol. Cell. Biol. 2003, 23:526-533.
6. Bartholin L., Powers S.E., Melhuish T.A., Lasse S., Weinstein M., Wotton D. TGIF inhibits retinoid signaling. Mol. Cell. Biol. 2006, 26:990-1001.
7. Bauer U.M., Daujat S., Nielsen S.J., Nightingale K., Kouzarides T. Methylation at arginine 17 of histone H3 is linked to gene activation. EMBO Rep. 2002, 3:39-44.
8. Bedford M.T., Richard S. Arginine methylation an emerging regulator of protein function. Mol. Cell 2005, 18:263-272.
9. Berriel Diaz M., Krones-Herzig A., Metzger D., Ziegler A., Vegiopoulos A., Klingenspor M., Muller-Decker K., Herzig S. Nuclear receptor cofactor receptor interacting protein 140 controls hepatic triglyceride metabolism during wasting in mice. Hepatology 2008, 48:782-791.
10. Bertolino E., Reimund B., Wildt-Perinic D., Clerc R.G. A novel homeobox protein which recognizes a TGT core and functionally interferes with a retinoid-responsive motif. J. Biol. Chem. 1995, 270:31178-31188.
11. Brownell J.E., Zhou J., Ranalli T., Kobayashi R., Edmondson D.G., Roth S.Y., Allis C.D. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 1996, 84:843-851.
12. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
13. Bugianesi E., McCullough A.J., Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005, 42:987-1000.
14. Burris T.P., Guo W., McCabe E.R. The gene responsible for adrenal hypoplasia congenita, DAX-1, encodes a nuclear hormone receptor that defines a new class within the superfamily. Recent Prog. Horm. Res. 1996, 51:241-259. discussion 259-260.
15. Casals N., Roca N., Guerrero M., Gil-Gomez G., Ayte J., Ciudad C.J., Hegardt F.G. Regulation of the expression of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene. Its role in the control of ketogenesis. Biochem. J. 1992, 283(Pt 1):261-264.
16. Casteels K., Mathieu C. Diabetic ketoacidosis. Rev. Endocr. Metab. Disord. 2003, 4:159-166.
17. Caton P.W., Nayuni N.K., Kieswich J., Khan N.Q., Yaqoob M.M., Corder R. Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5. J. Endocrinol. 2010, 205:97-106.
18. Cavailles V., Dauvois S., L'Horset F., Lopez G., Hoare S., Kushner P.J., Parker M.G. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 1995, 14:3741-3751.
19. Chen D., Ma H., Hong H., Koh S.S., Huang S.M., Schurter B.T., Aswad D.W., Stallcup M.R. Regulation of transcription by a protein methyltransferase. Science 1999, 284:2174-2177.
20. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw E.B., Kaestner K.H., Bartolomei M.S., Shulman G.I., Birnbaum M.J. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001, 292:1728-1731.
21. Chrivia J.C., Kwok R.P., Lamb N., Hagiwara M., Montminy M.R., Goodman R.H. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 1993, 365:855-859.
22. Clipsham R., McCabe E.R. DAX1 and its network partners: exploring complexity in development. Mol. Genet. Metab. 2003, 80:81-120.
23. Conkright M.D., Canettieri G., Screaton R., Guzman E., Miraglia L., Hogenesch J.B., Montminy M. TORCs: transducers of regulated CREB activity. Mol. Cell 2003, 12:413-423.
24. Consoli A. Role of liver in pathophysiology of NIDDM. Diabetes Care 1992, 15:430-441.
25. Coste A., Louet J.F., Lagouge M., Lerin C., Antal M.C., Meziane H., Schoonjans K., Puigserver P., O'Malley B.W., Auwerx J. The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1{alpha}. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:17187-17192.
26. Czech M.P., Buxton J.M. Insulin action on the internalization of the GLUT4 glucose transporter in isolated rat adipocytes. J. Biol. Chem. 1993, 268:9187-9190.
27. Dentin R., Hedrick S., Xie J., Yates J., Montminy M. Hepatic glucose sensing via the CREB coactivator CRTC2. Science 2008, 319:1402-1405.
28. Derks T.G., van Dijk T.H., Grefhorst A., Rake J.P., Smit G.P., Kuipers F., Reijngoud D.J. Inhibition of mitochondrial fatty acid oxidation in vivo only slightly suppresses gluconeogenesis but enhances clearance of glucose in mice. Hepatology 2008, 47:1032-1042.
29. Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 1999, 20:649-688.
30. Du K., Herzig S., Kulkarni R.N., Montminy M. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 2003, 300:1574-1577.
31. Duerden J.M., Bartlett S.M., Gibbons G.F. Regulation of very-low-density-lipoprotein lipid secretion in hepatocyte cultures derived from diabetic animals. Biochem. J. 1989, 262:313-319.
32. Duplus E., Glorian M., Forest C. Fatty acid regulation of gene transcription. J. Biol. Chem. 2000, 275:30749-30752.
33. Dvorin E., Gorder N.L., Benson D.M., Gotto A.M. Apolipoprotein A-IV. A determinant for binding and uptake of high density lipoproteins by rat hepatocytes. J. Biol. Chem. 1986, 261:15714-15718.
34. Engel N., Mahlknecht U. Aging and anti-aging: unexpected side effects of everyday medication through sirtuin1 modulation. Int. J. Mol. Med. 2008, 21:223-232.
35. Erion D.M., Yonemitsu S., Nie Y., Nagai Y., Gillum M.P., Hsiao J.J., Iwasaki T., Stark R., Weismann D., Yu X.X., Murray S.F., Bhanot S., Monia B.P., Horvath T.L., Gao Q., Samuel V.T., Shulman G.I. SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:11288-11293.
36. Fang S., Tsang S., Jones R., Ponugoti B., Yoon H., Wu S.Y., Chiang C.M., Willson T.M., Kemper J.K. The p300 acetylase is critical for ligand-activated farnesoid X receptor (FXR) induction of SHP. J. Biol. Chem. 2008, 283:35086-35095.
37. Feige J.N., Gelman L., Rossi D., Zoete V., Metivier R., Tudor C., Anghel S.I., Grosdidier A., Lathion C., Engelborghs Y., Michielin O., Wahli W., Desvergne B. The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. J. Biol. Chem. 2007, 282:19152-19166.
38. Francis G.A., Fayard E., Picard F., Auwerx J. Nuclear receptors and the control of metabolism. Annu. Rev. Physiol. 2003, 65:261-311.
39. Friedman J.E., Yun J.S., Patel Y.M., McGrane M.M., Hanson R.W. Glucocorticoids regulate the induction of phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes. J. Biol. Chem. 1993, 268:12952-12957.
40. Friedman J.E., Sun Y., Ishizuka T., Farrell C.J., McCormack S.E., Herron L.M., Hakimi P., Lechner P., Yun J.S. Phosphoenolpyruvate carboxykinase (GTP) gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db/db transgenic mice. J. Biol. Chem. 1997, 272:31475-31481.
41. Fritah A., Christian M., Parker M.G. The metabolic coregulator RIP140: an update. Am. J. Physiol. Endocrinol. Metab. 2010, 299(3):E335-E340.
42. Frye R.A. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem. Biophys. Res. Commun. 1999, 260:273-279.
43. Fu M., Rao M., Wang C., Sakamaki T., Wang J., Di Vizio D., Zhang X., Albanese C., Balk S., Chang C., Fan S., Rosen E., Palvimo J.J., Janne O.A., Muratoglu S., Avantaggiati M.L., Pestell R.G. Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol. Cell. Biol. 2003, 23:8563-8575.
44. Gibbons G.F., Islam K., Pease R.J. Mobilisation of triacylglycerol stores. Biochim. Biophys. Acta 2000, 1483:37-57.
45. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000, 14:121-141.
46. Gonzalez G.A., Montminy M.R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 1989, 59:675-680.
47. Guarente L. Calorie restriction and SIR2 genes-towards a mechanism. Mech. Ageing Dev. 2005, 126:923-928.
48. Guenther M.G., Barak O., Lazar M.A. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol. Cell. Biol. 2001, 21:6091-6101.
49. Hanada M., Feng J., Hemmings B.A. Structure, regulation and function of PKB/AKT-a major therapeutic target. Biochim. Biophys. Acta 2004, 1697:3-16.
50. Handschin C., Spiegelman B.M. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr. Rev. 2006, 27:728-735.
51. Hanson R.W., Reshef L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu. Rev. Biochem. 1997, 66:581-611.
52. Hegardt F.G. Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis. Biochem. J. 1999, 338(Pt 3):569-582.
53. Herzig S., Long F., Jhala U.S., Hedrick S., Quinn R., Bauer A., Rudolph D., Schutz G., Yoon C., Puigserver P., Spiegelman B., Montminy M. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001, 413:179-183.
54. Herzog B., Hallberg M., Seth A., Woods A., White R., Parker M.G. The nuclear receptor cofactor, receptor-interacting protein 140, is required for the regulation of hepatic lipid and glucose metabolism by liver X receptor. Mol. Endocrinol. 2007, 21:2687-2697.
55. Hu X., Li S., Wu J., Xia C., Lala D.S. Liver X receptors interact with corepressors to regulate gene expression. Mol. Endocrinol. 2003, 17:1019-1026.
56. Huang E.Y., Zhang J., Miska E.A., Guenther M.G., Kouzarides T., Lazar M.A. Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway. Genes Dev. 2000, 14:45-54.
57. Idris I., Gray S., Donnelly R. Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 2001, 44:659-673.
58. Iourgenko V., Zhang W., Mickanin C., Daly I., Jiang C., Hexham J.M., Orth A.P., Miraglia L., Meltzer J., Garza D., Chirn G.W., McWhinnie E., Cohen D., Skelton J., Terry R., Yu Y., Bodian D., Buxton F.P., Zhu J., Song C., Labow M.A. Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:12147-12152.
59. Iwasaki H. Impaired PRMT1 activity in the liver and pancreas of type 2 diabetic Goto-Kakizaki rats. Life Sci. 2009, 85:161-166.
60. Iyer A.K., McCabe E.R. Molecular mechanisms of DAX1 action. Mol. Genet. Metab. 2004, 83:60-73.
61. Jeong J.W., Kwak I., Lee K.Y., White L.D., Wang X.P., Brunicardi F.C., O'Malley B.W., DeMayo F.J. The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism. Mol. Endocrinol. 2006, 20:1138-1152.
62. Jhun B.H., Rampal A.L., Liu H., Lachaal M., Jung C.Y. Effects of insulin on steady state kinetics of GLUT4 subcellular distribution in rat adipocytes. Evidence of constitutive GLUT4 recycling. J. Biol. Chem. 1992, 267:17710-17715.
63. Jia Y., Qi C., Kashireddi P., Surapureddi S., Zhu Y.J., Rao M.S., Le Roith D., Chambon P., Gonzalez F.J., Reddy J.K. Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver. J. Biol. Chem. 2004, 279:24427-24434.
64. Jia Y., Viswakarma N., Fu T., Yu S., Rao M.S., Borensztajn J., Reddy J.K. Conditional ablation of mediator subunit MED1 (MED1/PPARBP) gene in mouse liver attenuates glucocorticoid receptor agonist dexamethasone-induced hepatic steatosis. Gene Expr. 2009, 14:291-306.
65. Jones P.L., Sachs L.M., Rouse N., Wade P.A., Shi Y.B. Multiple N-CoR complexes contain distinct histone deacetylases. J. Biol. Chem. 2001, 276:8807-8811.
66. Kaiser C., James S.R. Acetylation of insulin receptor substrate-1 is permissive for tyrosine phosphorylation. BMC Biol. 2004, 2:23.
67. Kaneko E., Matsuda M., Yamada Y., Tachibana Y., Shimomura I., Makishima M. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist. J. Biol. Chem. 2003, 278:36091-36098.
68. Khetchoumian K., Teletin M., Tisserand J., Mark M., Herquel B., Ignat M., Zucman-Rossi J., Cammas F., Lerouge T., Thibault C., Metzger D., Chambon P., Losson R. Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha. Nat. Genet. 2007, 39:1500-1506.
69. Khetchoumian K., Teletin M., Tisserand J., Herquel B., Ouararhni K., Losson R. Trim24 (Tif1 alpha): an essential 'brake' for retinoic acid-induced transcription to prevent liver cancer. Cell Cycle 2008, 7:3647-3652.
70. Kim J.K., Gavrilova O., Chen Y., Reitman M.L., Shulman G.I. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J. Biol. Chem. 2000, 275:8456-8460.
71. Knutson S.K., Chyla B.J., Amann J.M., Bhaskara S., Huppert S.S., Hiebert S.W. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J. 2008, 27:1017-1028.
72. Knutti D., Kralli A. PGC-1, a versatile coactivator. Trends Endocrinol. Metab. 2001, 12:360-365.
73. Knutti D., Kaul A., Kralli A. A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen. Mol. Cell. Biol. 2000, 20:2411-2422.
74. Kohler S., Cirillo L.A. Stable chromatin binding prevents FoxA acetylation, preserving FoxA chromatin remodeling. J. Biol. Chem. 2010, 285:464-472.
75. Koo S.H., Satoh H., Herzig S., Lee C.H., Hedrick S., Kulkarni R., Evans R.M., Olefsky J., Montminy M. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat. Med. 2004, 10:530-534.
76. Koo S.H., Flechner L., Qi L., Zhang X., Screaton R.A., Jeffries S., Hedrick S., Xu W., Boussouar F., Brindle P., Takemori H., Montminy M. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 2005, 437:1109-1111.
77. Kraus W.L., Wong J. Nuclear receptor-dependent transcription with chromatin. Is it all about enzymes?. Eur. J. Biochem. 2002, 269:2275-2283.
78. Krones-Herzig A., Mesaros A., Metzger D., Ziegler A., Lemke U., Bruning J.C., Herzig S. Signal-dependent control of gluconeogenic key enzyme genes through coactivator-associated arginine methyltransferase 1. J. Biol. Chem. 2006, 281:3025-3029.
79. Kruszynska Y.T., Olefsky J.M. Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. J. Investig. Med. 1996, 44:413-428.
80. Kwok R.P., Lundblad J.R., Chrivia J.C., Richards J.P., Bachinger H.P., Brennan R.G., Roberts S.G., Green M.R., Goodman R.H. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 1994, 370:223-226.
81. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
82. Lai P.H., Wang W.L., Ko C.Y., Lee Y.C., Yang W.M., Shen T.W., Chang W.C., Wang J.M. HDAC1/HDAC3 modulates PPARG2 transcription through the sumoylated CEBPD in hepatic lipogenesis. Biochim. Biophys. Acta 2008, 1783:1803-1814.
83. Lariviere F., Chiasson J.L., Schiffrin A., Taveroff A., Hoffer L.J. Effects of dietary protein restriction on glucose and insulin metabolism in normal and diabetic humans. Metabolism 1994, 43:462-467.
84. Leavens K.F., Easton R.M., Shulman G.I., Previs S.F., Birnbaum M.J. Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab. 2009, 10:405-418.
85. Lee Y.H., Stallcup M.R. Minireview: protein arginine methylation of nonhistone proteins in transcriptional regulation. Mol. Endocrinol. 2009, 23:425-433.
86. Lee J.W., Ryan F., Swaffield J.C., Johnston S.A., Moore D.D. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 1995, 374:91-94.
87. Lelliott C.J., Medina-Gomez G., Petrovic N., Kis A., Feldmann H.M., Bjursell M., Parker N., Curtis K., Campbell M., Hu P., Zhang D., Litwin S.E., Zaha V.G., Fountain K.T., Boudina S., Jimenez-Linan M., Blount M., Lopez M., Meirhaeghe A., Bohlooly Y.M., Storlien L., Stromstedt M., Snaith M., Oresic M., Abel E.D., Cannon B., Vidal-Puig A. Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol. 2006, 4:e369.
88. Lemaigre F.P., Rousseau G.G. Transcriptional control of genes that regulate glycolysis and gluconeogenesis in adult liver. Biochem. J. 1994, 303(Pt 1):1-14.
89. Lemke U., Krones-Herzig A., Berriel Diaz M., Narvekar P., Ziegler A., Vegiopoulos A., Cato A.C., Bohl S., Klingmuller U., Screaton R.A., Muller-Decker K., Kersten S., Herzig S. The glucocorticoid receptor controls hepatic dyslipidemia through Hes1. Cell Metab. 2008, 8:212-223.
90. Leonardsson G., Steel J.H., Christian M., Pocock V., Milligan S., Bell J., So P.W., Medina-Gomez G., Vidal-Puig A., White R., Parker M.G. Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8437-8442.
91. Lerin C., Rodgers J.T., Kalume D.E., Kim S.H., Pandey A., Puigserver P. GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha. Cell Metab. 2006, 3:429-438.
92. Lewis G.F., Carpentier A., Adeli K., Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 2002, 23:201-229.
93. Li J., Wang J., Nawaz Z., Liu J.M., Qin J., Wong J. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 2000, 19:4342-4350.
94. Li S., Liu C., Li N., Hao T., Han T., Hill D.E., Vidal M., Lin J.D. Genome-wide coactivation analysis of PGC-1alpha identifies BAF60a as a regulator of hepatic lipid metabolism. Cell Metab. 2008, 8:105-117.
95. Lin W.J., Gary J.D., Yang M.C., Clarke S., Herschman H.R. The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J. Biol. Chem. 1996, 271:15034-15044.
96. Lin J., Tarr P.T., Yang R., Rhee J., Puigserver P., Newgard C.B., Spiegelman B.M. PGC-1beta in the regulation of hepatic glucose and energy metabolism. J. Biol. Chem. 2003, 278:30843-30848.
97. Lin J., Yang R., Tarr P.T., Wu P.H., Handschin C., Li S., Yang W., Pei L., Uldry M., Tontonoz P., Newgard C.B., Spiegelman B.M. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell 2005, 120:261-273.
98. Linn T., Geyer R., Prassek S., Laube H. Effect of dietary protein intake on insulin secretion and glucose metabolism in insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 1996, 81:3938-3943.
99. Linn T., Santosa B., Gronemeyer D., Aygen S., Scholz N., Busch M., Bretzel R.G. Effect of long-term dietary protein intake on glucose metabolism in humans. Diabetologia 2000, 43:1257-1265.
100. Lopez D., Shea-Eaton W., Sanchez M.D., McLean M.P. DAX-1 represses the high-density lipoprotein receptor through interaction with positive regulators sterol regulatory element-binding protein-1a and steroidogenic factor-1. Endocrinology 2001, 142:5097-5106.
101. Matsumoto K., Yu S., Jia Y., Ahmed M.R., Viswakarma N., Sarkar J., Kashireddy P.V., Rao M.S., Karpus W., Gonzalez F.J., Reddy J.K. Critical role for transcription coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein/TRAP220 in liver regeneration and PPARalpha ligand-induced liver tumor development. J. Biol. Chem. 2007, 282:17053-17060.
102. McKenna N.J., O'Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002, 108:465-474.
103. Melhuish T.A., Wotton D. The Tgif2 gene contains a retained intron within the coding sequence. BMC Mol. Biol. 2006, 7:2.
104. Melhuish T.A., Gallo C.M., Wotton D. TGIF2 interacts with histone deacetylase 1 and represses transcription. J. Biol. Chem. 2001, 276:32109-32114.
105. Melhuish T.A., Chung D.D., Bjerke G.A., Wotton D. Tgif1 represses apolipoprotein gene expression in liver. J. Cell. Biochem. 2010, 111(2):380-390.
106. Michael M.D., Kulkarni R.N., Postic C., Previs S.F., Shulman G.I., Magnuson M.A., Kahn C.R. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 2000, 6:87-97.
107. Moller D.E. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001, 414:821-827.
108. Nedumaran B., Hong S., Xie Y.B., Kim Y.H., Seo W.Y., Lee M.W., Lee C.H., Koo S.H., Choi H.S. DAX-1 acts as a novel corepressor of orphan nuclear receptor HNF4alpha and negatively regulates gluconeogenic enzyme gene expression. J. Biol. Chem. 2009, 284:27511-27523.
109. Nedumaran B., Kim G.S., Hong S., Yoon Y.S., Kim Y.H., Lee C.H., Lee Y.C., Koo S.H., Choi H.S. Orphan nuclear receptor DAX-1 acts as a novel corepressor of liver X receptor alpha and inhibits hepatic lipogenesis. J. Biol. Chem. 2010, 285:9221-9232.
110. Nie Y., Erion D.M., Yuan Z., Dietrich M., Shulman G.I., Horvath T.L., Gao Q. STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nat. Cell Biol. 2009, 11:492-500.
111. Nikolaidou-Neokosmidou V., Zannis V.I., Kardassis D. Inhibition of hepatocyte nuclear factor 4 transcriptional activity by the nuclear factor kappaB pathway. Biochem. J. 2006, 398:439-450.
112. Nofsinger R.R., Li P., Hong S.H., Jonker J.W., Barish G.D., Ying H., Cheng S.Y., Leblanc M., Xu W., Pei L., Kang Y.J., Nelson M., Downes M., Yu R.T., Olefsky J.M., Lee C.H., Evans R.M. SMRT repression of nuclear receptors controls the adipogenic set point and metabolic homeostasis. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:20021-20026.
113. Nordlie R.C., Foster J.D., Lange A.J. Regulation of glucose production by the liver. Annu. Rev. Nutr. 1999, 19:379-406.
114. O'Brien R.M., Granner D.K. Regulation of gene expression by insulin. Biochem. J. 1991, 278(Pt 3):609-619.
115. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996, 87:953-959.
116. Onate S.A., Tsai S.Y., Tsai M.J., O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995, 270:1354-1357.
117. Park E.J., Lee J.H., Yu G.Y., He G., Ali S.R., Holzer R.G., Osterreicher C.H., Takahashi H., Karin M. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010, 140:197-208.
118. Picard F., Gehin M., Annicotte J., Rocchi S., Champy M.F., O'Malley B.W., Chambon P., Auwerx J. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 2002, 111:931-941.
119. Pilkis S.J., Granner D.K. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu. Rev. Physiol. 1992, 54:885-909.
120. Puigserver P., Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 2003, 24:78-90.
121. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92:829-839.
122. Puigserver P., Adelmant G., Wu Z., Fan M., Xu J., O'Malley B., Spiegelman B.M. Activation of PPARgamma coactivator-1 through transcription factor docking. Science 1999, 286:1368-1371.
123. Puigserver P., Rhee J., Donovan J., Walkey C.J., Yoon J.C., Oriente F., Kitamura Y., Altomonte J., Dong H., Accili D., Spiegelman B.M. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 2003, 423:550-555.
124. Qi C., Zhu Y., Pan J., Yeldandi A.V., Rao M.S., Maeda N., Subbarao V., Pulikuri S., Hashimoto T., Reddy J.K. Mouse steroid receptor coactivator-1 is not essential for peroxisome proliferator-activated receptor alpha-regulated gene expression. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:1585-1590.
125. Rodgers J.T., Lerin C., Gerhart-Hines Z., Puigserver P. Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways. FEBS Lett. 2008, 582:46-53.
126. Rosenfeld M.G., Glass C.K. Coregulator codes of transcriptional regulation by nuclear receptors. J. Biol. Chem. 2001, 276:36865-36868.
127. Rosmond R., Bjorntorp P. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J. Intern. Med. 2000, 247:188-197.
128. Rossetti L., Rothman D.L., DeFronzo R.A., Shulman G.I. Effect of dietary protein on in vivo insulin action and liver glycogen repletion. Am. J. Physiol. 1989, 257:E212-E219.
129. Saltiel A.R. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 2001, 104:517-529.
130. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
131. Satoh S., Nishimura H., Clark A.E., Kozka I.J., Vannucci S.J., Simpson I.A., Quon M.J., Cushman S.W., Holman G.D. Use of bismannose photolabel to elucidate insulin-regulated GLUT4 subcellular trafficking kinetics in rat adipose cells. Evidence that exocytosis is a critical site of hormone action. J. Biol. Chem. 1993, 268:17820-17829.
132. Schwarz J.M., Linfoot P., Dare D., Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am. J. Clin. Nutr. 2003, 77:43-50.
133. Screaton R.A., Conkright M.D., Katoh Y., Best J.L., Canettieri G., Jeffries S., Guzman E., Niessen S., Yates J.R., Takemori H., Okamoto M., Montminy M. The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 2004, 119:61-74.
134. Shiba T., Inoguchi T., Sportsman J.R., Heath W.F., Bursell S., King G.L. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am. J. Physiol. 1993, 265:E783-E793.
135. Shulman G.I. Cellular mechanisms of insulin resistance. J. Clin. Invest. 2000, 106:171-176.
136. Son Y.L., Lee Y.C. Molecular determinants of the interactions between LXR/RXR heterodimers and TRAP220. Biochem. Biophys. Res. Commun. 2009, 384:389-393.
137. Spiegelman B.M., Heinrich R. Biological control through regulated transcriptional coactivators. Cell 2004, 119:157-167.
138. Sterner D.E., Berger S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 2000, 64:435-459.
139. Thiagalingam S., Cheng K.H., Lee H.J., Mineva N., Thiagalingam A., Ponte J.F. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann. N. Y. Acad. Sci. 2003, 983:84-100.
140. Unger R.H., Orci L. Glucagon and the A cell: physiology and pathophysiology (second of two parts). N. Engl. J. Med. 1981, 304:1575-1580.
141. Unno A., Takada I., Takezawa S., Oishi H., Baba A., Shimizu T., Tokita A., Yanagisawa J., Kato S. TRRAP as a hepatic coactivator of LXR and FXR function. Biochem. Biophys. Res. Commun. 2005, 327:933-938.
142. Valera A., Pujol A., Pelegrin M., Bosch F. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:9151-9154.
143. Vianna C.R., Huntgeburth M., Coppari R., Choi C.S., Lin J., Krauss S., Barbatelli G., Tzameli I., Kim Y.B., Cinti S., Shulman G.I., Spiegelman B.M., Lowell B.B. Hypomorphic mutation of PGC-1beta causes mitochondrial dysfunction and liver insulin resistance. Cell Metab. 2006, 4:453-464.
144. Wang H., Huang Z.Q., Xia L., Feng Q., Erdjument-Bromage H., Strahl B.D., Briggs S.D., Allis C.D., Wong J., Tempst P., Zhang Y. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 2001, 293:853-857.
145. Wang Y., Vera L., Fischer W.H., Montminy M. The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis. Nature 2009, 460:534-537.
146. Winston F., Carlson M. Yeast SNF/SWI transcriptional activators and the SPT/SIN chromatin connection. Trends Genet. 1992, 8:387-391.
147. Wolffe A.P., Pruss D. Targeting chromatin disruption: transcription regulators that acetylate histones. Cell 1996, 84:817-819.
148. Wolfrum C., Stoffel M. Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion. Cell Metab. 2006, 3:99-110.
149. Wotton D., Lo R.S., Swaby L.A., Massague J. Multiple modes of repression by the Smad transcriptional corepressor TGIF. J. Biol. Chem. 1999, 274:37105-37110.
150. Xu J., Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol. Endocrinol. 2003, 17:1681-1692.
151. Xu J., O'Malley B.W. Molecular mechanisms and cellular biology of the steroid receptor coactivator (SRC) family in steroid receptor function. Rev. Endocr. Metab. Disord. 2002, 3:185-192.
152. Yan J., Gao Z., Yu G., He Q., Weng J., Ye J. Nuclear corepressor is required for inhibition of phosphoenolpyruvate carboxykinase expression by tumor necrosis factor-alpha. Mol. Endocrinol. 2007, 21:1630-1641.
153. Yan J.H., Gao Z.G., Ye J.P., Weng J.P. Exchange of a nuclear corepressor between NF-kappaB and CREB mediates inhibition of phosphoenolpyruvate carboxykinase transcription by NF-kappaB. Chin. Med. J. (Engl.) 2010, 123:221-226.
154. Yanagisawa J., Kitagawa H., Yanagida M., Wada O., Ogawa S., Nakagomi M., Oishi H., Yamamoto Y., Nagasawa H., McMahon S.B., Cole M.D., Tora L., Takahashi N., Kato S. Nuclear receptor function requires a TFTC-type histone acetyl transferase complex. Mol. Cell 2002, 9:553-562.
155. Yoon J.C., Puigserver P., Chen G., Donovan J., Wu Z., Rhee J., Adelmant G., Stafford J., Kahn C.R., Granner D.K., Newgard C.B., Spiegelman B.M. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001, 413:131-138.
156. Yoshida Y., Hughes D.E., Rausa F.M., Kim I.M., Tan Y., Darlington G.J., Costa R.H. C/EBPalpha and HNF6 protein complex formation stimulates HNF6-dependent transcription by CBP coactivator recruitment in HepG2 cells. Hepatology 2006, 43:276-286.
157. You S.H., Liao X., Weiss R.E., Lazar M.A. The interaction between nuclear receptor corepressor and histone deacetylase 3 regulates both positive and negative thyroid hormone action in vivo. Mol. Endocrinol. 2010, 24(7):1359-1367.
158. Zammit V.A. Role of insulin in hepatic fatty acid partitioning: emerging concepts. Biochem. J. 1996, 314(Pt 1):1-14.
159. Zammit V.A., Moir A.M. Monitoring the partitioning of hepatic fatty acids in vivo: keeping track of control. Trends Biochem. Sci. 1994, 19:313-317.
160. Zhang L., Rubins N.E., Ahima R.S., Greenbaum L.E., Kaestner K.H. Foxa2 integrates the transcriptional response of the hepatocyte to fasting. Cell Metab. 2005, 2:141-148.
161. Zhang Y.L., Hernandez-Ono A., Siri P., Weisberg S., Conlon D., Graham M.J., Crooke R.M., Huang L.S., Ginsberg H.N. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. J. Biol. Chem. 2006, 281:37603-37615.
162. Zhou X.Y., Shibusawa N., Naik K., Porras D., Temple K., Ou H., Kaihara K., Roe M.W., Brady M.J., Wondisford F.E. Insulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein. Nat. Med. 2004, 10:633-637.
163. Zhu Y., Qi C., Jain S., Rao M.S., Reddy J.K. Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor. J. Biol. Chem. 1997, 272:25500-25506.
164. Zschiedrich I., Hardeland U., Krones-Herzig A., Berriel Diaz M., Vegiopoulos A., Muggenburg J., Sombroek D., Hofmann T.G., Zawatzky R., Yu X., Gretz N., Christian M., White R., Parker M.G., Herzig S. Coactivator function of RIP140 for NFkappaB/RelA-dependent cytokine gene expression. Blood 2008, 112:264-276.